ArticleMolecular biotechnology2024

Docking and Molecular Dynamics Simulation Revealed the Potential Inhibitory Activity of Amygdalin in Triple-Negative Breast Cancer Therapeutics Targeting the BRCT Domain of BARD1 Receptor.

Prarthana Chatterjee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.